Vinpocetine and Cerebral Insufficiency (Research)
- Balestreri, R., et al. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatric Society. 35:425-430, 1987.
- Dean, W. & Morgenthaler, J. Smart Drugs & Nutrients. B & J Publications, Santa Cruz, California, USA. 1990:71-75.
- DeNoble, V., et al. Vinpocetine: Nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats. Pharmacology Biochemistry & Behaviour. 24:1123-1128, 1986.
- Faloon, W. Staying mentally sharp: European ‘smart drug’ now a dietary supplement. Life Extension. 4(12):12-15, 1998.
- Hadjiev, D. Rheoencephalographic and psychologic studies with ethyl apovincaminate in cerebral vascular insufficiency. Arzneimittelforschung [Drug Research]. 26(10a):1947-1950, 1976.
- Manconi, E., et al. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. Curr Ther Res Clin Exp. 40:702-709, 1986.
- Otomo, E., et al. Comparison of vinpocetine with efenprodil tartrate and dihydroergotoxine mesylate treatment and results of long-term treatment with vinpocetine. Curr Ther Res Clin Exp. 37:811-821, 1985.
- Tohgi, H., et al. Effect of vinpocetine on oxygen release of hemoglobin and erythrocyte organic polyphosphate concentrations in patients with vascular dementia of the Bingwaner type. Arzneim Forsch Drug Res. 40:640-643, 1990.
- Creating mental clarity. Life Enhancement. June 1998:3-8.
- Gedeon Richter Ltd. Vinpocetine Product Literature.
